SCHEMBL7340557

SCHEMBL7340557

COC(CCOS(=O)(=O)c1ccc(C)cc1)CCOS(=O)(=O)c1ccc(C)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.41
CA9 Q16790 3/20 0.41
CA1 P00915 2/20 0.41
STAT3 P40763 1/20 0.40
GAA P10253 1/20 0.39
CYP2D6 P10635 2/20 0.39
CYP1A2 P05177 1/20 0.39
ALDH1A1 P00352 5/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
HTT P42858 1/20 0.39
PSMD10 O75832 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
AGER Q15109 1/20 0.38
CA2 P00918 2/20 0.37
VDR P11473 1/20 0.37
CA3 P07451 1/20 0.37
CA6 P23280 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28038882 0.92 CA12 (0.39) CA12CA9CA1STAT3GAA
SCHEMBL17693358 0.92 ALDH1A1 (0.39) CA12CA9CA1STAT3GAA
SCHEMBL4204331 0.89 MCHR1 (0.41) CA12CA9CA1STAT3ALDH1A1
SCHEMBL4204339 0.89 MCHR1 (0.41) CA12CA9CA1STAT3ALDH1A1
SCHEMBL4204335 0.89 MCHR1 (0.41) CA12CA9CA1STAT3ALDH1A1
SCHEMBL12371510 0.85 CA9 (0.40) CA12CA9CA1STAT3GAA
SCHEMBL31754943 0.84 ALDH1A1 (0.38) CA12CA9CA1STAT3GAA
SCHEMBL30831511 0.84 ALDH1A1 (0.38) CA12CA9CA1STAT3GAA
SCHEMBL8663719 0.84 CA12 (0.41) CA12CA9CA1STAT3GAA
SCHEMBL17233364 0.83 CA9 (0.43) CA12CA9CA1STAT3GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820573-A1 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES Novartis AG (CH) 2021-05-19 EP disclosed
WO-2020012334-A1 3-(5-HYDROXY-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND THEIR USE IN THE TREATMENT OF IKAROS FAMILY ZINC FINGER 2 (IKZF2)-DEPENDENT DISEASES NOVARTIS AG (CH) 2020-01-16 WO disclosed
US-5849780-A 1-benzenesulfonyl-1-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present SANOFI (FR) 1998-12-15 US disclosed
US-5728723-A ANTIDIURETIC AND OXYTOCIN RECEPTORS SANOFI (FR) 1998-03-17 US disclosed
US-5726322-A 1-benzenesulfonyl-1,3-dihydroindol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present SANOFI (FR) 1998-03-10 US disclosed
US-5696145-A VASOPRESSIN AND OXYTOCIN RECEPTOR SANOFI (FR) 1997-12-09 US disclosed
US-5686624-A 1-benzenesulfonyl-1,3-dihydro-indol-2-one derivatives, their preparation and pharmaceutical compositions in which they are present SANOFI (FR) 1997-11-11 US disclosed
US-5663431-A CHEMICAL INTERMEDIATES SANOFI (FR) 1997-09-02 US disclosed
US-5618833-A USEFUL FOR TREATING OR PREVENTING VASOPRESSIN OR OXYTOCIN DEPENDANT COMPLAINTS SANOFI (FR) 1997-04-08 US disclosed
EP-0636608-A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-indol-2-one, their preparation and pharmaceutical compositions containing them SANOFI (FR) 1995-02-01 EP disclosed
EP-0636609-A1 1-Benzyl-1,3-dihydro-indol-2-one derivatives, their preparation, the pharmaceutical compositions containing them SANOFI (FR) 1995-02-01 EP disclosed